Aptar Pharma will showcase its diverse portfolio of drug delivery systems, components, active packaging, and digital health solutions at the in-person CPhI Worldwide in Frankfurt, which will take place on 1-3 November 2022.
Each year, the CPHI unites more than 100,000 pharmaceutical professionals through exhibitions, conferences, and online communities to network, identify business opportunities and expand the global market.
At Booth #30C40, Aptar Pharma will also feature its latest innovations across nasal, pulmonary, eye care, injectables, and dermal drug delivery routes.
Aptar will explain to visitors how it is focusing on delivering a more sustainable future with solutions to support a more circular approach and how it is expanding to increase capacity and add capabilities worldwide for its injectables customers.
The company is providing continuous support and decentralized care to enhance patient experiences via Aptar Digital Health, which recently launched a new Disease Management Platform.
Aptar CSP Technologies will present its portfolio of active material science solutions for protecting drug delivery systems, with experts explaining Aptar CSP’s Co-Development Program for accelerating and de-risking the drug development process.
On 1 November, Aptar Pharma will present two sessions on ‘biologics for nasal delivery’ and ‘moving patients training from clinical to home settings’.
In this year’s 2022 CPhI Pharma Awards, Aptar Pharma is a finalist in the Excellence in Pharma: Digital Innovation category for Oleena Digital Therapeutic for Symptom Management in Oncology.
In the Excellence in Pharma: Packaging & Drug Delivery category, Noble, an Aptar Pharma company, has been named as a co-finalist for the Safe ‘n’ Sound Patient Onboarding Kit.
The winners of this year’s CPhI Pharma Awards will be announced on November 1.
